MiMedx Group, Inc. Sales Revenue, Goods, Net (Deprecated 2018-01-31)
MiMedx Group, Inc. (MDXG) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $84.57 million for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-10-31.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsNet · last filed 2017-10-31
- MiMedx Group, Inc. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $84.57M, a 31.27% increase year-over-year.
- MiMedx Group, Inc. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $76.41M, a 33.26% increase year-over-year.
- MiMedx Group, Inc. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $72.61M, a 36.05% increase year-over-year.
- MiMedx Group, Inc. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2016-12-31 was $69.88M, a 34.81% increase year-over-year.
- MiMedx Group, Inc. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2016 was $245.01M, a 30.82% increase from fiscal 2015.
- MiMedx Group, Inc. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2015 was $187.30M, a 58.43% increase from fiscal 2014.
- MiMedx Group, Inc. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2014 was $118.22M, a 99.77% increase from fiscal 2013.
- MiMedx Group, Inc. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2013 was $59.18M, a 118.76% increase from fiscal 2012.
| Period end | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-09-30 | $84.57M 10-Q · filed 2017-10-31 | $160.99M derived: sum of 2 quarters · filed 2017-10-31 | $233.59M 10-Q · filed 2017-10-31 | $303.47M derived: sum of 4 quarters · filed 2017-10-31 | ||||
| 2017-06-30 | $76.41M 10-Q · filed 2017-07-31 | $149.02M 10-Q · filed 2017-07-31 | $218.90M derived: sum of 3 quarters · filed 2017-07-31 | $283.32M derived: sum of 4 quarters · filed 2017-10-31 | ||||
| 2017-03-31 | $72.61M 10-Q · filed 2017-05-01 | $142.48M derived: sum of 2 quarters · filed 2017-05-01 | $206.91M derived: sum of 3 quarters · filed 2017-10-31 | $264.25M derived: sum of 4 quarters · filed 2017-10-31 | ||||
| 2016-12-31 | $69.88M 10-K · filed 2017-03-01 | $134.31M derived: sum of 2 quarters · filed 2017-10-31 | $191.65M derived: sum of 3 quarters · filed 2017-10-31 | $245.01M 10-K · filed 2017-03-01 | ||||
| 2016-09-30 | $64.43M 10-Q · filed 2017-10-31 | $121.77M derived: sum of 2 quarters · filed 2017-10-31 | $175.14M 10-Q · filed 2017-10-31 | $226.97M derived: sum of 4 quarters · filed 2017-10-31 | ||||
| 2016-06-30 | $57.34M 10-Q · filed 2017-07-31 | $110.71M 10-Q · filed 2017-07-31 | $162.54M derived: sum of 3 quarters · filed 2017-07-31 | $211.56M derived: sum of 4 quarters · filed 2017-07-31 | ||||
| 2016-03-31 | $53.37M 10-Q · filed 2017-05-01 | $105.20M derived: sum of 2 quarters · filed 2017-05-01 | $154.22M derived: sum of 3 quarters · filed 2017-05-01 | $199.90M derived: sum of 4 quarters · filed 2017-05-01 | ||||
| 2015-12-31 | $51.84M 10-K · filed 2017-03-01 | $100.85M derived: sum of 2 quarters · filed 2017-03-01 | $146.53M derived: sum of 3 quarters · filed 2017-03-01 | $187.30M 10-K · filed 2017-03-01 | ||||
| 2015-09-30 | $49.02M 10-K · filed 2017-03-01 | $94.69M derived: sum of 2 quarters · filed 2017-03-01 | $135.46M 10-Q · filed 2016-11-08 | $175.03M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-06-30 | $45.68M 10-K · filed 2017-03-01 | $86.45M 10-Q · filed 2016-08-02 | $126.02M derived: sum of 3 quarters · filed 2017-03-01 | $159.54M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-03-31 | $40.77M 10-K · filed 2017-03-01 | $80.34M derived: sum of 2 quarters · filed 2017-03-01 | $113.86M derived: sum of 3 quarters · filed 2017-03-01 | $139.43M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2014-12-31 | $39.57M 10-K · filed 2017-02-22 | $73.09M derived: sum of 2 quarters · filed 2017-02-22 | $98.66M derived: sum of 3 quarters · filed 2017-02-22 | $118.22M 10-K · filed 2017-03-01 | ||||
| 2014-09-30 | $33.52M 10-K · filed 2017-02-22 | $33.52M 10-Q · filed 2014-11-10 | $59.09M derived: sum of 2 quarters · filed 2017-02-22 | $78.65M 10-Q · filed 2015-11-06 | $78.65M 10-Q · filed 2014-11-10 | $96.64M derived: sum of 4 quarters · filed 2017-02-22 | ||
| 2014-06-30 | $25.57M 10-K · filed 2017-02-22 | $25.57M 10-Q · filed 2014-08-11 | $45.13M 10-Q · filed 2015-08-07 | $45.13M 10-Q · filed 2014-08-11 | $63.13M derived: sum of 3 quarters · filed 2017-02-22 | $79.24M derived: sum of 4 quarters · filed 2017-02-22 | ||
| 2014-03-31 | $19.56M 10-K · filed 2017-02-22 | $19.56M 10-Q · filed 2014-05-12 | $37.55M derived: sum of 2 quarters · filed 2017-02-22 | $53.67M derived: sum of 3 quarters · filed 2017-02-22 | $67.18M derived: sum of 4 quarters · filed 2017-02-22 | |||
| 2013-12-31 | $17.99M 10-K · filed 2017-02-22 | $17.99M 10-K · filed 2014-03-04 | $34.11M derived: sum of 2 quarters · filed 2017-02-22 | $47.63M derived: sum of 3 quarters · filed 2017-02-22 | $59.18M 10-K · filed 2017-02-22 | $59.18M 10-K · filed 2014-03-04 | ||
| 2013-09-30 | $16.12M 10-K · filed 2017-02-22 | $16.12M 10-Q · filed 2013-11-08 | $29.63M derived: sum of 2 quarters · filed 2017-02-22 | $41.19M 10-Q · filed 2014-11-10 | $51.70M derived: sum of 4 quarters · filed 2017-02-22 | |||
| 2013-06-30 | $13.52M 10-K · filed 2017-02-22 | $13.51M 10-Q · filed 2013-08-08 | $25.07M 10-Q · filed 2014-08-11 | $35.58M derived: sum of 3 quarters · filed 2017-02-22 | $43.53M derived: sum of 4 quarters · filed 2017-02-22 | |||
| 2013-03-31 | $11.56M 10-K · filed 2017-02-22 | $11.56M 10-Q · filed 2013-05-10 | $22.07M derived: sum of 2 quarters · filed 2017-02-22 | $30.02M derived: sum of 3 quarters · filed 2017-02-22 | $34.90M derived: sum of 4 quarters · filed 2017-02-22 | |||
| 2012-12-31 | $10.51M 10-K · filed 2015-03-13 | $10.51M 10-K · filed 2014-03-04 | $18.46M derived: sum of 2 quarters · filed 2015-03-13 | $23.35M derived: sum of 3 quarters · filed 2015-03-13 | $27.05M 10-K · filed 2015-03-13 | $27.05M 10-K · filed 2013-03-15 | ||
| 2012-09-30 | $7.95M 10-K · filed 2015-03-13 | $7.95M 10-Q · filed 2012-11-13 | $12.84M derived: sum of 2 quarters · filed 2015-03-13 | $16.54M 10-Q · filed 2013-11-08 | $19.18M derived: sum of 4 quarters · filed 2015-03-13 | |||
| 2012-06-30 | $4.88M 10-K · filed 2015-03-13 | $4.88M 10-Q · filed 2012-08-14 | $8.59M 10-Q · filed 2013-08-08 | $11.23M derived: sum of 3 quarters · filed 2015-03-13 | $13.38M derived: sum of 4 quarters · filed 2015-03-13 | |||
| 2012-03-31 | $3.71M 10-K · filed 2015-03-13 | $3.71M 10-Q · filed 2012-05-14 | $6.34M derived: sum of 2 quarters · filed 2015-03-13 | $8.49M derived: sum of 3 quarters · filed 2015-03-13 | $10.42M derived: sum of 4 quarters · filed 2015-03-13 | |||
| 2011-12-31 | $2.64M 10-K · filed 2014-03-04 | $4.79M derived: sum of 2 quarters · filed 2014-03-04 | $6.72M derived: sum of 3 quarters · filed 2014-03-04 | $7.76M 10-K · filed 2014-03-04 | ||||
| 2011-09-30 | $2.15M 10-K · filed 2014-03-04 | $4.08M derived: sum of 2 quarters · filed 2014-03-04 | $5.12M 10-Q · filed 2012-11-13 | $5.12M derived: sum of 4 quarters · filed 2014-03-04 | ||||
| 2011-06-30 | $1.93M 10-K · filed 2014-03-04 | $2.97M 10-Q · filed 2012-08-14 | $2.97M derived: sum of 3 quarters · filed 2014-03-04 | $3.08M derived: sum of 4 quarters · filed 2014-03-04 | ||||
| 2011-03-31 | $1.04M 10-K · filed 2014-03-04 | $1.04M derived: sum of 2 quarters · filed 2014-03-04 | $1.15M derived: sum of 3 quarters · filed 2014-03-04 | $1.47M derived: sum of 4 quarters · filed 2014-03-04 | ||||
| 2010-12-31 | -$801.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | $107.23K derived: sum of 2 quarters · filed 2012-03-29 | $429.30K derived: sum of 3 quarters · filed 2012-03-29 | $544.15K 10-K · filed 2012-03-29 | ||||
| 2010-09-30 | $108.03K 10-Q · filed 2011-11-14 | $430.10K derived: sum of 2 quarters · filed 2011-11-14 | $544.96K 10-Q · filed 2011-11-14 | |||||
| 2010-06-30 | $322.07K 10-Q · filed 2011-08-04 | $436.93K 10-Q · filed 2011-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |